Vimarsana
Biggest News Aggregation in the World

Page 6 - Nucleus Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nucleus Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nucleus Network Today - Breaking & Trending Today

NFL LEGEND BRETT FAVRE AND ODYSSEY HEALTH, INC. INVOLVED - Vimarsana News

NFL LEGEND BRETT FAVRE AND ODYSSEY HEALTH, INC. INVOLVED

IRVINE, CA, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. f/k/a Odyssey Group International, Inc. (OTC Pink: ODYY) today announced the...

NFL LEGEND BRETT FAVRE AND ODYSSEY HEALTH, INC. INVOLVED WITH HUMAN TRIALS OF FIRST DRUG TREATMENT FOR CONCUSSION - Vimarsana News

NFL LEGEND BRETT FAVRE AND ODYSSEY HEALTH, INC. INVOLVED WITH HUMAN TRIALS OF FIRST DRUG TREATMENT FOR CONCUSSION

IRVINE, CA, Feb. 11, 2022 -- Odyssey Health, Inc. f/k/a Odyssey Group International, Inc. today announced the continued enrollment of its first in kind human clinical trial of its proprietary... | February 11, 2022

Blackstone Tees Up $11 Billion in Fresh Capital for Asia Deals - Vimarsana News

Blackstone Tees Up $11 Billion in Fresh Capital for Asia Deals

(Bloomberg) — Blackstone Inc. has amassed $11 billion to buy companies in Asia after raising its second private-equity fund for the region, nearly tripling its…

Quadrant buys a slice of clinical trials biz Southern Star Research - Vimarsana News

Quadrant buys a slice of clinical trials biz Southern Star Research

Quadrant Private Equity is the latest to join the dealmaking frenzy for clinical trials outfits.

Source: afr.com
Blackstone buys Crescent Capital's Nucleus Network - Vimarsana News

Blackstone buys Crescent Capital's Nucleus Network

Global investment manager Blackstone has agreed terms to acquire clinical trials provider Nucleus Network from Australian private equity firm Crescent Capital. 

Source: afr.com